UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy

Clinical and experimental allergy, 2024-02, Vol.54 (2), p.130-142

2024

Volltextzugriff (PDF)

The mode of action of sugammadex on coagulation

International journal of clinical pharmacology and therapeutics, 2021-02, Vol.59 (2), p.89

2021

Volltextzugriff (PDF)

Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma

Journal of allergy and clinical immunology, 2019-03, Vol.143 (3), p.970-977

2019

Volltextzugriff (PDF)

Dogmas, challenges, and promises in phase III allergen immunotherapy studies

The World Allergy Organization journal, 2021-09, Vol.14 (9), p.100578-100578, Article 100578

2021

Volltextzugriff (PDF)

Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT ® )

Frontiers in immunology, 2020-11, Vol.11, p.594911-594911

2020

Volltextzugriff (PDF)

Development of In Vitro–In Vivo Correlation for Extended‐Release Niacin After Administration of Hypromellose‐Based Matrix Formulations to Healthy Volunteers

Journal of pharmaceutical sciences, 2014-11, Vol.103 (11), p.3713-3723

2014

Volltextzugriff (PDF)

Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects

International journal of clinical pharmacology and therapeutics, 2014-03, Vol.52 (3), p.227

2014

Volltextzugriff (PDF)

Pharmacokinetics of sugammadex 16 mg/kg in healthy Chinese volunteers

International journal of clinical pharmacology and therapeutics, 2015-06, Vol.53 (6), p.456

2015

Volltextzugriff (PDF)

An Exploratory Field Study With A Subcutaneously Administered Tyrosine Adsorbed Modified Grass Allergen + MPL

Journal of allergy and clinical immunology, 2021-02, Vol.147 (2), p.AB128-AB128

2021

Volltextzugriff (PDF)

Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study

International journal of clinical pharmacology and therapeutics, 2012-08, Vol.50 (8), p.595

2012

Volltextzugriff (PDF)

Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects

International journal of clinical pharmacology and therapeutics, 2014-08, Vol.52 (8), p.631

2014

Volltextzugriff (PDF)

Discovery and Clinical Evaluation of MK‐8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide Release

Journal of the American Heart Association, 2016-09, Vol.5 (9), p.n/a

2016

Volltextzugriff (PDF)

No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters

International journal of clinical pharmacology and therapeutics, 2013-12, Vol.51 (12), p.976

2013

Volltextzugriff (PDF)

Single therapeutic and supratherapeutic doses of corifollitropin alfa, a sustained follicle stimulant, do not prolong the QTcF-interval in healthy postmenopausal volunteers

International journal of clinical pharmacology and therapeutics, 2015-09, Vol.53 (9), p.772

2015

Volltextzugriff (PDF)

Flucloxacillin and Diclofenac do not Cause Recurrence of Neuromuscular Blockade after Reversal with Sugammadex

Clinical drug investigation, 2012-03, Vol.32 (3), p.203-212

2012

Volltextzugriff (PDF)

SCIT-treatment With a Chemically Modified, Aluminum Hydroxide Adsorbed Peanut Extract (HAL-MPE1) Was Generally Safe And Well Tolerated And Showed Immunological Changes In Peanut Allergic Patients

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB191-AB191

2017

Volltextzugriff (PDF)

A PK-PD model-based assessment of sugammadex effects on coagulation parameters

European journal of pharmaceutical sciences, 2016-03, Vol.84, p.9-17

2016

Volltextzugriff (PDF)

Protein C/S ratio, an accurate and simple tool to identify carriers of a protein C gene mutation

British journal of haematology, 2002-08, Vol.118 (2), p.615-618

2002

Volltextzugriff (PDF)

The Effect of Therapeutic and Supratherapeutic Oral Doses of Nomegestrol Acetate (NOMAC)/17β-Estradiol (E2) on QTcF Intervals in Healthy Women: Results from a Randomized, Double-Blind, Placebo- and Positive-Controlled Trial

Clinical drug investigation, 2014-06, Vol.34 (6), p.413-420

2014

Volltextzugriff (PDF)

Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy Subjects

American journal of therapeutics, 2015-09, Vol.22 (5), p.367

2015

Volltextzugriff (PDF)

Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women

Journal of the American College of Cardiology, 1999-11, Vol.34 (6), p.1760-1768

1999

Volltextzugriff (PDF)

The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin

Platelets (Edinburgh), 2014-11, Vol.25 (7), p.480-487

2014

Volltextzugriff (PDF)

Baseline Conjunctival Provocation Testing Score Predicts Grass-Specific Immunoglobulin Response

Journal of allergy and clinical immunology, 2022-02, Vol.149 (2), p.AB50-AB50

2022

Volltextzugriff (PDF)

Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype

Psychopharmacologia, 2011-05, Vol.215 (2), p.321-332

2011

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Humans
(41)
Female
(30)
Male
(30)
Middle Aged
(29)
Adult
(27)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Cardiovascular System & Cardiology
(17)
Pharmacology & Pharmacy
(17)
Aged
(16)
Cardiac & Cardiovascular Systems
(15)
Double-Blind Method
(15)
Adolescent
(14)
Cross-Over Studies
(14)
Young Adult
(12)
Pharmacology. Drug Treatments
(10)
Pharmacokinetics
(8)
Atrial Fibrillation - Physiopathology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy

Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report

The mode of action of sugammadex on coagulation

Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma

Dogmas, challenges, and promises in phase III allergen immunotherapy studies

Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT ® )

Development of In Vitro–In Vivo Correlation for Extended‐Release Niacin After Administration of Hypromellose‐Based Matrix Formulations to Healthy Volunteers

Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects

Pharmacokinetics of sugammadex 16 mg/kg in healthy Chinese volunteers

An Exploratory Field Study With A Subcutaneously Administered Tyrosine Adsorbed Modified Grass Allergen + MPL

Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study

Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects

Discovery and Clinical Evaluation of MK‐8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide Release

No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters

Single therapeutic and supratherapeutic doses of corifollitropin alfa, a sustained follicle stimulant, do not prolong the QTcF-interval in healthy postmenopausal volunteers

Flucloxacillin and Diclofenac do not Cause Recurrence of Neuromuscular Blockade after Reversal with Sugammadex

SCIT-treatment With a Chemically Modified, Aluminum Hydroxide Adsorbed Peanut Extract (HAL-MPE1) Was Generally Safe And Well Tolerated And Showed Immunological Changes In Peanut Allergic Patients

A PK-PD model-based assessment of sugammadex effects on coagulation parameters

Protein C/S ratio, an accurate and simple tool to identify carriers of a protein C gene mutation

The Effect of Therapeutic and Supratherapeutic Oral Doses of Nomegestrol Acetate (NOMAC)/17β-Estradiol (E2) on QTcF Intervals in Healthy Women: Results from a Randomized, Double-Blind, Placebo- and Positive-Controlled Trial

Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy Subjects

Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women

The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin

Baseline Conjunctival Provocation Testing Score Predicts Grass-Specific Immunoglobulin Response

Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype

Suchergebnisse filtern